[Characteristics and Risk Analysis of COVID-19 Infection in Patients with Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation] [0.03%]
[自身造血干细胞移植后多发性骨髓瘤患者感染新冠肺炎的临床特征和风险分析]
Meng-Meng Pan,Shi-Wei Jin,Wan-Yan Ouyang et al.
Meng-Meng Pan et al.
Objective: To retrospectively analyze the characteristics and influencing factors of COVID-19 infection in patients with multiple myeloma (MM) who underwent autologous hematopoietic stem cell transplantation (AHSCT). ...
[Effects of Prognostic Nutritional Index and Systemic Inflammatory Response Index on Short-Term Efficacy and Prognosis in Patients with Peripheral T-Cell Lymphoma] [0.03%]
[预后营养指数和全身炎症反应指数对周围T细胞淋巴瘤近期疗效及预后的价值分析]
Zi-Qing Huang,Yan-Hui Li,Bin Lyu et al.
Zi-Qing Huang et al.
Objective: To investigate the predictive value of the prognostic nutritional index (PNI) and systemic inflammatory response index (SIRI) for short-term efficacy and prognosis in newly treated patients with peripheral T-ce...
[The Relationship between the Expression of SATB1 and Clinicopathological Features and Prognosis of Diffuse Large B-Cell Lymphoma] [0.03%]
SATB1表达与弥漫大B细胞淋巴瘤临床病理特征及预后的关系
Jie Sun,Guang-Yao Yu,Sha He et al.
Jie Sun et al.
Objective: To investigate the expression of specific AT sequence binding protein 1 (SATB1) in diffuse large B cell lymphoma (DLBCL) and its relationship with clinicopathological features and prognosis. ...
[Comparative Study of Baseline 18F-FDG PET/CT and Circulating Tumor DNA in Prognostic Assessment of Diffuse Large B-Cell Lymphoma] [0.03%]
[基线~(18)F-FDG PET/CT与循环肿瘤DNA在弥漫大B细胞淋巴瘤预后评估中的比较研究]
Jia-Lin Li,Rui Wang,Min Bai et al.
Jia-Lin Li et al.
Objective: To analyze the correlation between baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) and circulating tumor DNA (ctDNA) parameters in diffuse large B-cell lymphoma...
[Clinical Features and Prognostic Analysis of Diffuse Large B-Cell Lymphoma in the Elderly] [0.03%]
老年弥漫性大B细胞淋巴瘤的临床特点和预后分析
Li-Yuan Chu,Ding-Dan Zhang,Ya-Yue Zhang et al.
Li-Yuan Chu et al.
Objective: To investigate the clinical characteristics and prognostic factors of elderly patients with diffuse large B-cell lymphoma (DLBCL). Methods: ...
[CircRAD18 Regulates Daunorubicin Resistance in Acute Myeloid Leukemia Cells through MiR-185-5p/ HDGF Axis] [0.03%]
circrad18通过miR-185-5p/hdgc轴调节急性髓系白血病细胞柔红霉素耐药性
Hui Sun,Fei-Fei Yang,Hao Tang
Hui Sun
Objective: To investigate the mechanism of circular RNA RAD18 (CircRAD18 ) in regulating daunorubicin (DNR) resistance in acute myeloid leukemia (AML) cells through the miR-185-5p/hepatoma-derived growth factor ( HDGF) ax...
[Effects of Down-regulation of NCL Expression on the Biological Behavior of Acute Myeloid Leukemia Kasumi-1 Cells] [0.03%]
下调NCL表达对急性髓系白血病Kasumi-1细胞生物行为的影响
Hui-Li Liu,Wen-Xin Xu,Yang-Yan Cai et al.
Hui-Li Liu et al.
Objective: To investigate the role of nucleolin (NCL) in acute myeloid leukemia (AML) Kasumi-1 cells and its underlying mechanism. Methods: ...
[Screening of Anti-Tumor Drugs that Enhance Antigen Presentation of AML Cells with TCR-Like Antibody] [0.03%]
[T细胞受体样抗体筛选增强急性髓系白血病抗原呈递的抗肿瘤药物]
Xiao-Ying Yang,Bo Tang,Hui-Hui Liu et al.
Xiao-Ying Yang et al.
Objective: To screen anti-tumor drugs that improve antigen processing and presentation in acute myeloid leukemia (AML) cells. Methods: ...
[Correlation between Expression Levels of Tim-3, C-myc and Proportion of T Lymphocyte Subsets and Prognosis in Patients with Acute Lymphoblastic Leukemia] [0.03%]
TIM-3、C-MYC表达及T淋巴细胞亚群比例与急性淋巴细胞白血病患者预后的相关性研究
Yu-Chai Zhong,Ke-Ding Hu,Yi-Rong Jiang et al.
Yu-Chai Zhong et al.
Objective: To analyze the correlation between the expression levels of Tim-3, C-myc and the proportion of T lymphocyte subsets and prognosis in patients with acute lymphoblastic leukemia (ALL). ...
[Characterization of Acute Myeloid Leukemia Patients with DEK-NUP214 Fusion Gene Positive] [0.03%]
DEK-NUP214阳性急性髓系白血病患者的临床特征分析
Ran Huang,Yuan-Bing Wu,Ya-Xue Wu et al.
Ran Huang et al.
Objective: To analyze the clinical features of acute myeloid leukemia patients with DEK-NUP214 fusion gene positive. Methods: The DEK-N...